Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 39

1.

Predictors of biologic-free disease control in patients with rheumatoid arthritis after stopping tumor necrosis factor inhibitor treatment.

Ghiti Moghadam M, Lamers-Karnebeek FBG, Vonkeman HE, Ten Klooster PM, Tekstra J, van Schaeybroeck B, Klaasen R, van Onna M, Bernelot Moens HJ, Visser H, Schilder AM, Kok MR, Landewé RBM, van Riel PLCM, van de Laar MAFJ, Jansen TL; Dutch National POET Collaboration.

BMC Rheumatol. 2019 Jun 13;3:3. doi: 10.1186/s41927-019-0071-x. eCollection 2019.

2.

Multi-biomarker disease activity score as a predictor of disease relapse in patients with rheumatoid arthritis stopping TNF inhibitor treatment.

Ghiti Moghadam M, Lamers-Karnebeek FBG, Vonkeman HE, Ten Klooster PM, Tekstra J, Schilder AM, Visser H, Sasso EH, Chernoff D, Lems WF, van Schaardenburg DJ, Landewe R, Bernelot Moens HJ, Radstake TRDJ, van Riel PLCM, van de Laar MAFJ, Jansen TL; Dutch National POET Collaboration.

PLoS One. 2018 May 23;13(5):e0192425. doi: 10.1371/journal.pone.0192425. eCollection 2018.

3.

An Economic Evaluation of Stopping Versus Continuing Tumor Necrosis Factor Inhibitor Treatment in Rheumatoid Arthritis Patients With Disease Remission or Low Disease Activity: Results From a Pragmatic Open-Label Trial.

Tran-Duy A, Ghiti Moghadam M, Oude Voshaar MAH, Vonkeman HE, Boonen A, Clarke P, McColl G, Ten Klooster PM, Zijlstra TR, Lems WF, Riyazi N, Griep EN, Hazes JMW, Landewé R, Bernelot Moens HJ, van Riel PLCM, van de Laar MAFJ, Jansen TL; Dutch National POET Collaboration.

Arthritis Rheumatol. 2018 Oct;70(10):1557-1564. doi: 10.1002/art.40546. Epub 2018 Aug 23.

PMID:
29745059
4.

Dermatological guidelines for monitoring methotrexate treatment reduce drug-survival compared to rheumatological guidelines.

Busger Op Vollenbroek FTM, Doggen CJM, Janssens RWA, Bernelot Moens HJ.

PLoS One. 2018 Mar 23;13(3):e0194401. doi: 10.1371/journal.pone.0194401. eCollection 2018.

5.

Feasibility of photoacoustic/ultrasound imaging of synovitis in finger joints using a point-of-care system.

van den Berg PJ, Daoudi K, Bernelot Moens HJ, Steenbergen W.

Photoacoustics. 2017 Aug 31;8:8-14. doi: 10.1016/j.pacs.2017.08.002. eCollection 2017 Dec.

6.

Validation of automatic joint space width measurements in hand radiographs in rheumatoid arthritis.

Schenk O, Huo Y, Vincken KL, van de Laar MA, Kuper IH, Slump KC, Lafeber FP, Bernelot Moens HJ.

J Med Imaging (Bellingham). 2016 Oct;3(4):044502. Epub 2016 Nov 23.

7.

Further Simplification of the Simple Erosion Narrowing Score With Item Response Theory Methodology.

Oude Voshaar MA, Schenk O, Ten Klooster PM, Vonkeman HE, Bernelot Moens HJ, Boers M, van de Laar MA.

Arthritis Care Res (Hoboken). 2016 Aug;68(8):1206-10. doi: 10.1002/acr.22793.

8.

Stopping Tumor Necrosis Factor Inhibitor Treatment in Patients With Established Rheumatoid Arthritis in Remission or With Stable Low Disease Activity: A Pragmatic Multicenter, Open-Label Randomized Controlled Trial.

Ghiti Moghadam M, Vonkeman HE, Ten Klooster PM, Tekstra J, van Schaardenburg D, Starmans-Kool M, Brouwer E, Bos R, Lems WF, Colin EM, Allaart CF, Meek IL, Landewé R, Bernelot Moens HJ, van Riel PL, van de Laar MA, Jansen TL; Dutch National POET Collaboration.

Arthritis Rheumatol. 2016 Aug;68(8):1810-7. doi: 10.1002/art.39626.

9.

[Temporal arteritis: do not rely on the erythrocyte sedimentation rate].

Bernelot Moens HJ.

Ned Tijdschr Geneeskd. 2015;159:A9196. Review. Dutch.

PMID:
26332818
10.

Validity and measurement precision of the PROMIS physical function item bank and a content validity-driven 20-item short form in rheumatoid arthritis compared with traditional measures.

Oude Voshaar MA, Ten Klooster PM, Glas CA, Vonkeman HE, Taal E, Krishnan E, Bernelot Moens HJ, Boers M, Terwee CB, van Riel PL, van de Laar MA.

Rheumatology (Oxford). 2015 Dec;54(12):2221-9. doi: 10.1093/rheumatology/kev265. Epub 2015 Jul 29.

PMID:
26224306
11.

Green light may improve diagnostic accuracy of nailfold capillaroscopy with a simple digital videomicroscope.

Weekenstroo HH, Cornelissen BM, Bernelot Moens HJ.

Rheumatol Int. 2015 Jun;35(6):1069-71. doi: 10.1007/s00296-014-3193-x. Epub 2014 Dec 16.

PMID:
25510292
12.

Initial results of finger imaging using photoacoustic computed tomography.

van Es P, Biswas SK, Bernelot Moens HJ, Steenbergen W, Manohar S.

J Biomed Opt. 2014 Jun;19(6):060501. doi: 10.1117/1.JBO.19.6.060501.

PMID:
24887742
13.

Treating to the target of remission in early rheumatoid arthritis is cost-effective: results of the DREAM registry.

Vermeer M, Kievit W, Kuper HH, Braakman-Jansen LM, Bernelot Moens HJ, Zijlstra TR, den Broeder AA, van Riel PL, Fransen J, van de Laar MA.

BMC Musculoskelet Disord. 2013 Dec 13;14:350. doi: 10.1186/1471-2474-14-350.

14.

Changes in Farr radioimmunoassay and EliA fluorescence immunoassay anti-dsDNA in relation to exacerbation of SLE.

Hillebrand JJ, Bernelot Moens HJ, Mulder AH.

Lupus. 2013 Oct;22(11):1169-73. doi: 10.1177/0961203313500368. Epub 2013 Aug 8.

PMID:
23929638
15.

Adherence to a treat-to-target strategy in early rheumatoid arthritis: results of the DREAM remission induction cohort.

Vermeer M, Kuper HH, Bernelot Moens HJ, Hoekstra M, Posthumus MD, van Riel PL, van de Laar MA.

Arthritis Res Ther. 2012 Nov 23;14(6):R254. doi: 10.1186/ar4099.

16.

Determinants of engagement in face-to-face and online patient support groups.

Van Uden-Kraan CF, Drossaert CH, Taal E, Smit WM, Bernelot Moens HJ, Van de Laar MA.

J Med Internet Res. 2011 Dec 7;13(4):e106. doi: 10.2196/jmir.1718.

17.

Long-term effectiveness and safety of TNF-blocking agents in daily clinical practice: results from the Dutch Rheumatoid Arthritis Monitoring register.

Kievit W, Fransen J, Adang EM, den Broeder AA, Bernelot Moens HJ, Visser H, van de Laar MA, van Riel PL.

Rheumatology (Oxford). 2011 Jan;50(1):196-203. doi: 10.1093/rheumatology/keq325. Epub 2010 Nov 14.

PMID:
21078625
18.

Automated measurement of joint space width in small joints of patients with rheumatoid arthritis.

Lukas C, Sharp JT, Angwin J, Boers M, Duryea J, Hall JR, Kauffman JA, Landewé R, Langs G, Bernelot Moens HJ, Peloschek P, van der Heijde D.

J Rheumatol. 2008 Jul;35(7):1288-93. Epub 2008 Jun 15.

PMID:
18597408
19.

Computer based methods for measurement of joint space width: update of an ongoing OMERACT project.

Sharp JT, Angwin J, Boers M, Duryea J, von Ingersleben G, Hall JR, Kauffman JA, Landewé R, Langs G, Lukas C, Maillefert JF, Bernelot Moens HJ, Peloschek P, Strand V, van der Heijde D.

J Rheumatol. 2007 Apr;34(4):874-83.

PMID:
17407243
20.

Leflunomide in the treatment of rheumatoid arthritis. An analysis of predictors for treatment continuation.

van Roon EN, Hoekstra M, Tobi H, Jansen TL, Bernelot Moens HJ, Brouwers JR, van de Laar MA.

Br J Clin Pharmacol. 2005 Sep;60(3):319-25.

21.

Spa treatment for primary fibromyalgia syndrome: a combination of thalassotherapy, exercise and patient education improves symptoms and quality of life.

Zijlstra TR, van de Laar MA, Bernelot Moens HJ, Taal E, Zakraoui L, Rasker JJ.

Rheumatology (Oxford). 2005 Apr;44(4):539-46. Epub 2005 Feb 3.

PMID:
15695301
22.

Longterm observational study of methotrexate use in a Dutch cohort of 1022 patients with rheumatoid arthritis.

Hoekstra M, van de Laar MA, Bernelot Moens HJ, Kruijsen MW, Haagsma CJ.

J Rheumatol. 2003 Nov;30(11):2325-9.

PMID:
14677172
23.

Differences in understanding and application of 1987 ACR criteria for rheumatoid arthritis and 1991 ESSG criteria for spondylarthropathy. A pilot survey.

Berthelot JM, Bernelot-Moens HJ, Klarlund M, McGonagle D, Calin A, Schumacher HR, Combe B, De Bandt M, Drosos AA, Flipo RM, Harris BJ, Kaarela K, Le Goff P, Meyer O, Punzi L, Zerbini CA, Saraux A; CRI Group.

Clin Exp Rheumatol. 2002 Mar-Apr;20(2):145-50.

PMID:
12051392
24.
25.

Lessons from an international survey of paper cases of 10 real patients from an early arthritis clinic. CRI (Club Rhumatismes et Inflammation) Group.

Berthelot JM, Klarlund M, McGonagle D, Bernelot-Moens HJ, Calin A, Harrison B, Schumacher HR, Kaarela K, Drosos AA, Hülsemann JL, Koh WH, Konttinen YT, Punzi L, Tanimoto K, Williams HJ, Wolfe F, Zerbini CA, Saraux A; Club Rheumatismes et Inflammation Group.

J Rheumatol. 2001 May;28(5):975-81.

PMID:
11361225
26.

[Immunology in the medical practice. XXI. Laboratory tests for immunologic diseases].

Bernelot Moens HJ.

Ned Tijdschr Geneeskd. 1999 Nov 13;143(46):2343-4. Dutch. No abstract available.

PMID:
10589233
27.

No increased risk of malignancies and mortality in cyclosporin A-treated patients with rheumatoid arthritis.

van den Borne BE, Landewé RB, Houkes I, Schild F, van der Heyden PC, Hazes JM, Vandenbroucke JP, Zwinderman AH, Goei The HS, Breedveld FC, Bernelot Moens HJ, Kluin PM, Dijkmans BA.

Arthritis Rheum. 1998 Nov;41(11):1930-7.

PMID:
9811046
28.

Laboratory screening for side effects of disease modifying antirheumatic drugs in daily rheumatological practice.

Simon CH, Vliet Vlieland TP, Dijkmans BA, Bernelot Moens HJ, Janssen M, Hazes JM, Franken HC, Vandenbroucke JP, Breedveld FC.

Scand J Rheumatol. 1998;27(3):170-9.

PMID:
9645411
29.

Silicone breast prostheses and rheumatic symptoms: a retrospective follow up study.

Giltay EJ, Bernelot Moens HJ, Riley AH, Tan RG.

Ann Rheum Dis. 1994 Mar;53(3):194-6.

30.

[Number of admissions for Reiter's disease (ICD-9-code 099.3) in Dutch hospitals in the period 1981-1987].

Miedema HS, van de Laar MA, Bernelot Moens HJ, Rasker JJ.

Ned Tijdschr Geneeskd. 1993 May 1;137(18):928. Dutch. No abstract available.

PMID:
8492839
32.
33.

Comparison of the sensitivity and specificity of the 1958 and 1987 criteria for rheumatoid arthritis.

Bernelot Moens HJ, van de Laar MA, van der Korst JK.

J Rheumatol. 1992 Feb;19(2):198-203.

PMID:
1629817
34.

Assessment of inflammatory joint activity in rheumatoid arthritis and changes in atmospheric conditions.

van de Laar MA, Bernelot Moens HJ, van der Stadt RJ, van der Korst JK.

Clin Rheumatol. 1991 Dec;10(4):426-33.

PMID:
1802500
35.

Comparison of rheumatological diagnoses by a Bayesian program and by physicians.

Bernelot Moens HJ, van der Korst JK.

Methods Inf Med. 1991 Aug;30(3):187-93.

PMID:
1943790
36.

Perivascular infiltration in normal skin of patients with rheumatoid arthritis: association with rheumatoid factors and HLA-DR antigens.

Bernelot Moens HJ, Ament HJ, Vroom TM, Feltkamp TE, van der Korst JK.

Ann Rheum Dis. 1988 Oct;47(10):838-42.

37.

Radiosynoviorthesis of the knee: a doubleblind trial of 1 versus 5 mCi Gold-198.

Van Soesbergen RM, Hoefnagel CA, Marcuse HR, Dijkstra PF, Bernelot Moens HJ.

Clin Rheumatol. 1988 Jun;7(2):224-30.

PMID:
2843316
38.

[Can reactive arthritis be caused by Chlamydia trachomatis?].

Bernelot Moens HJ.

Ned Tijdschr Geneeskd. 1987 Jan 24;131(4):144-6. Dutch. No abstract available.

PMID:
3821994
39.

[Polymyalgia rheumatica: definition of a disease picture].

Bernelot Moens HJ, van der Korst JK.

Ned Tijdschr Geneeskd. 1985 Jul 6;129(27):1272-5. Dutch. No abstract available.

PMID:
4033812

Supplemental Content

Loading ...
Support Center